Dynapenia Could Predict Chemotherapy-Induced Dose-Limiting Neurotoxicity in Digestive Cancer Patients

BMC Cancer - United Kingdom
doi 10.1186/s12885-018-4860-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Could HE4 Level Measurements During First-Line Chemotherapy Predict Response to Treatment Among Ovarian Cancer Patients?

PLoS ONE
Multidisciplinary
2018English

Maintaining Dose Intensity of Adjuvant Chemotherapy in Older Patients With Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2018English

Chemotherapy Could Be Given at Patients' Workplace

BMJ
2001English

High XIST and Low 53BP1 Expression Predict Poor Outcome After High-Dose Alkylating Chemotherapy in Patients With a BRCA1-like Breast Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2015English

Preoperative Chemotherapy in Gastric Cancer: Expanding the Indications, Limiting the Overuse

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2014English

High-Dose Chemotherapy in High-Risk Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2000English

Leptotrichia Bacteremia in Patients Receiving High-Dose Chemotherapy

Journal of Clinical Microbiology
Microbiology
2011English

Chemotherapy-Induced Neuropathy in Cancer Survivors

Journal of Pain and Symptom Management
NeurologyAnesthesiologyPain MedicineNursing
2017English

High-Dose Chemotherapy (CTM) for Breast Cancer

Bone Marrow Transplantation
TransplantationHematology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy